Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Frantz

Showing results (211-220 of 247) with videos related to

Pageof 25
Sort By:
Circulation|November 18, 2009
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trialDouglas L Packer, Jordan M Prutkin, Anne S Hellkamp, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 29, 2008
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathyMartha Q Lacy, Angela Dispenzieri, Suzanne R Hayman, et al.
Circulation. Heart Failure|June 19, 2026
Phenotypic Characterization of Unclassified Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Alexander C Egbe, et al.
Circulation. Heart Failure|February 25, 2020
Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease: Insights From the PVDOMICS ProgramW H Wilson Tang, Jennifer D Wilcox, Miriam S Jacob, et al.
European Journal of Heart Failure|June 5, 2024
Pulmonary hypertension across the spectrum of left heart and lung diseaseBarry A Borlaug, Brett Larive, Robert P Frantz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 23, 2025
Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantationRuben J Crespo-Diaz, Adrian J daSilva-deAbreu, Andrew N Rosenbaum, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2026
Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial HypertensionRobin Osterhout, Athénaïs Boucly, Raymond L Benza, et al.
The European Respiratory Journal|February 19, 2026
Pathophysiology and prevalence of high output heart failure in group 1 pulmonary hypertensionYogesh N V Reddy, Robert P Frantz, William R Miranda, et al.
Pulmonary Circulation|April 18, 2025
Physical Activity, Sleep, and Quality of Life in Pulmonary Arterial Hypertension: Novel Insights From Wearable DevicesAndrew M Hughes, Alisha Lindsey, Jeffrey Annis, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 27, 2015
Long-term safety and efficacy of imatinib in pulmonary arterial hypertensionAdaani E Frost, Robyn J Barst, Marius M Hoeper, et al.
Pageof 25

Showing results (211-220 of 247) with videos related to

Sort By:
Pageof 25
Circulation|November 18, 2009
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trialDouglas L Packer, Jordan M Prutkin, Anne S Hellkamp, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 29, 2008
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathyMartha Q Lacy, Angela Dispenzieri, Suzanne R Hayman, et al.
Circulation. Heart Failure|June 19, 2026
Phenotypic Characterization of Unclassified Pulmonary HypertensionYogesh N V Reddy, Robert P Frantz, Alexander C Egbe, et al.
Circulation. Heart Failure|February 25, 2020
Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease: Insights From the PVDOMICS ProgramW H Wilson Tang, Jennifer D Wilcox, Miriam S Jacob, et al.
European Journal of Heart Failure|June 5, 2024
Pulmonary hypertension across the spectrum of left heart and lung diseaseBarry A Borlaug, Brett Larive, Robert P Frantz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 23, 2025
Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantationRuben J Crespo-Diaz, Adrian J daSilva-deAbreu, Andrew N Rosenbaum, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2026
Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial HypertensionRobin Osterhout, Athénaïs Boucly, Raymond L Benza, et al.
The European Respiratory Journal|February 19, 2026
Pathophysiology and prevalence of high output heart failure in group 1 pulmonary hypertensionYogesh N V Reddy, Robert P Frantz, William R Miranda, et al.
Pulmonary Circulation|April 18, 2025
Physical Activity, Sleep, and Quality of Life in Pulmonary Arterial Hypertension: Novel Insights From Wearable DevicesAndrew M Hughes, Alisha Lindsey, Jeffrey Annis, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 27, 2015
Long-term safety and efficacy of imatinib in pulmonary arterial hypertensionAdaani E Frost, Robyn J Barst, Marius M Hoeper, et al.
Pageof 25